🇺🇸 FDA

Company profile · Sponsor

Dianthus

Dianthus Therapeutics, Inc. /DE/

DNTH · NYSE pharma NEW YORK, NY, USA
Pipeline
6
Drugs
0
Patents
2

Quick answer

Dianthus (DNTH) is a pharma company. headquartered in NEW YORK, NY, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 2 patents to this profile..

Company facts

Ticker DNTH
Exchange NYSE
Company type pharma
Headquarters NEW YORK, NY, USA
SEC CIK 0001690585

Pipeline (6)

Search pipeline →

  1. Claseprubart

    Dianthus

    Chronic Inflammatory Demyelinating Polyneuropathy

    phase 3 small molecule active

    1 trial

  2. Placebo matching DNTH103, DNTH103

    Dianthus

    Chronic Inflammatory Demyelinating Polyneuropathy

    phase 3 small molecule active

    1 trial

  3. Claseprubart

    Dianthus

    Multifocal Motor Neuropathy

    phase 2 small molecule active

    1 trial

  4. DNTH103

    Dianthus

    Myasthenia Gravis, Generalized

    phase 2 small molecule active

    1 trial

  5. DNTH103, Matching placebo to DNTH103

    Dianthus

    Multifocal Motor Neuropathy

    phase 2 small molecule active

    1 trial

  6. Placebo to match DNTH103, Nimenrix powder and solvent for solution for injection in pre-filled syringe Meningococcal groups A, C, W-135 and Y conjugate vaccine, DNTH103, Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNA, component, adsorbed), Nimenrix powder and solvent for solution for injection in pre-filled syringe Meningococcal groups A, C, W-135 and Y conjugate vaccine, Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNA, c

    Dianthus

    Generalized Myasthenia Gravis

    phase 2 small molecule active

    1 trial

Patents (2)

Search patents →

  1. US 12252550

    Antibodies that bind to C1S and uses thereof

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12110344

    Antibodies that bind to cis and uses thereof

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Dianthus?

Dianthus (DNTH) is a pharma company. headquartered in NEW YORK, NY, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 2 patents to this profile..

What pipeline programs does Dianthus sponsor?

We track 6 ClinicalTrials.gov-linked programs for Dianthus, including Claseprubart and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Dianthus company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.